Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind Placebo-Controlled, Non-Inferiority, Multi-Center Study of the Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

NCT05799378 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05799378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05799378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind Placebo-Controlled, Non-Inferiority, Multi-Center Study of the Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Lead sponsor
NYU Langone Health
Phase
Phase 3
Overall status
Recruiting
Start date
June 27, 2024
Completion date
June 30, 2029
Enrollment
330 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus